Efficacy and Actions of Pidotimod Oral Solution
Pidotimod is a non-specific immunostimulant commonly prescribed for children over three years of age and elderly individuals with compromised immune function. However, robust clinical evidence supporting its efficacy in enhancing immunity or reducing the incidence of infectious diseases remains lacking. In contrast, thymopentin—a similarly immunomodulatory agent—has demonstrated more definitive clinical benefits, particularly in patients with chronic hepatitis B and malignant tumors, where it is explicitly indicated to improve immune function.

Therapeutic Effects and Clinical Applications of Pidotimod Oral Solution
Pidotimod oral solution is a synthetic immunostimulatory and immunomodulatory agent that exerts its effects by activating nonspecific innate immunity, humoral immunity, and cellular immunity.
Clinically, pidotimod oral solution enhances host immune defense and is used in the management of upper and lower respiratory tract infections—including pharyngitis, bronchitis, and tracheitis. It also demonstrates beneficial effects in otolaryngological conditions such as rhinitis, tonsillitis, sinusitis, and otitis media. Additionally, it may be employed to modulate immune function in patients with urinary tract infections or gynecological infectious diseases. As an adjunctive therapy during acute infection, it may help reduce disease severity, shorten the duration of illness, and prevent recurrent episodes. For optimal absorption, pidotimod should be administered separately from meals—not concurrently.
Otolaryngological infections—including rhinitis, tonsillitis, sinusitis, and otitis media—may benefit from immune modulation with pidotimod. It is also indicated for immune regulation in urinary tract and gynecological infections. Furthermore, it serves as an adjunctive therapy during acute infections to mitigate disease severity, accelerate recovery, and reduce recurrence risk.

Important Precautions for Pidotimod Oral Solution
1. Food intake may impair drug absorption; therefore, administration should be separated from meals by a suitable interval.
2. Although animal studies have shown no adverse effects on the reproductive system, caution is advised during the first trimester of pregnancy—as with other medications.
3. Patients with a history of hypersensitivity reactions should use pidotimod with caution.
4. Do not use beyond the stated expiration date.

The above outlines the therapeutic effects, indications, and precautions associated with pidotimod oral solution. We hope this information is helpful to you.